Column

Clinical Pathways GPS

Population Health Delivery Through Health Systems and Pharma

09/06/2016

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

As health systems become more prevalent, they are having increasing levels of control over treatment decisions, in coordination with physicians and managed care organizations. As a result of this increased level of...

As...

09/06/2016

Journal of Clinical Pathways

Pharma Insights

Clarity Regarding Prostate Cancer Screening, Why Payers Need It Too

09/06/2016

Jeremy Schafer , PharmD, MBA;

Controversy over the lack of a survival benefit associated with early diagnosis of prostate cancer through prostate-specific antigen (PSA) screening has led to uncertainty in the determination of PSA coverage and its...

...

09/06/2016

Journal of Clinical Pathways

Editor's Page

A Greater Focus on the Patient

09/06/2016

Winston Wong , PharmD;

One of the core goals of clinical pathways development has always been to make health care more patient-centered. However, a common complaint regarding clinical pathway development is that patients are often left out...

One of...

09/06/2016

Journal of Clinical Pathways

Pharma Insights

The Rising Use of Oncology Value Tools By Payers

08/02/2016

Kellie Rademacher , PharmD;

Jeremy Schafer , PharmD, MBA;

Janet Serluco , MS;

Attributing value in the rapidly expanding oncology space is a new challenge to payers looking to introduce a range of novel therapies where older drugs have long dominated. Rising costs across all levels of cancer...

...

08/02/2016

Journal of Clinical Pathways

Clinical Pathways GPS

Impact of Quality of Life on Clinical Pathways

08/02/2016

Jill Cantelmo , DPhil, MSc;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Seth Gordon , MBA;

For clinical pathway developers seeking to define the value of different treatments, quality-of-life (QOL) measures offer a means of capturing the factors that most define value to the patient and their caregivers....

For...

08/02/2016

Journal of Clinical Pathways

Editor's Page

Can Value Frameworks Effect Real Change in Health Care?

08/02/2016

Winston Wong , PharmD;

The concept of value in health care has become increasingly important, and this is unlikely to change any time soon. Health care reforms have been proposed in order to slow the increase in health care costs while...

The...

08/02/2016

Journal of Clinical Pathways

Pharma Insights

Could the Lack of an Efficient and Affordable Diagnostic Pathway Limit Market Access for New Alzheimer`s Treatments?

06/20/2016

Rick Lifsitz , MBA;

Larry Blandford , PharmD;

The promise in the coming years of a novel therapeutic to slow the progression of the debilitating effects of Alzheimer’s disease (AD) is exciting and represents a monumental step forward in treating patients with...

The...

06/20/2016

Journal of Clinical Pathways

Clinical Pathways GPS

Beyond Medication Class: How Specific Should the Clinical Pathway Get?

06/20/2016

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Taha Khan , PharmD, RPh;

Aspects of a medication beyond the chemical composition can have an impact on patient outcomes. Consideration of these aspects when developing clinical pathways may result in particular formulations or delivery...

...

06/20/2016

Journal of Clinical Pathways

Editor's Page

Pathways for Improving Quality of Life

06/20/2016

Winston Wong , PharmD;

As early detection of cancers and improved treatments continue to improve outcomes for patients with cancer, care providers have been able to increase their focus on the quality of life for patients with cancer who...

As...

06/20/2016

Journal of Clinical Pathways

Counterpoint

Keeping Cures on the Shelf

05/06/2016

George Dahlman ;

Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done. During 2010 and 2011, the news headlines were filled with...

...

05/06/2016

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products